{"id":757,"date":"2025-07-09T03:44:12","date_gmt":"2025-07-09T03:44:12","guid":{"rendered":"http:\/\/60.204.213.123\/?page_id=757"},"modified":"2025-07-09T03:45:16","modified_gmt":"2025-07-09T03:45:16","slug":"mart1-27-35-hla-a0201-6","status":"publish","type":"page","link":"https:\/\/www.guixiong.com.cn\/?page_id=757","title":{"rendered":"Envelope protein (183-191) HLA-A*02:01 \u6d41\u5f0f\u9a8c\u8bc1"},"content":{"rendered":"\n

\u9776\u70b9\u8bf4\u660e<\/h3>\n\n\n\n

Envelope protein (183-191) FLLTRILTI HLA-A*02:01 \u6765\u81eaHBV\uff0c\u5176\u591a\u80bdFLLTRILTI\u662f\u4e00\u79cd\u7ebf\u6027\u80bd\u8868\u4f4d\uff08\u8868\u4f4dID 16755\uff09\uff0c\u4f5c\u4e3a\u4e59\u578b\u809d\u708e\u75c5\u6bd2\uff08\u4eba\u7c7b\u4e59\u578b\u809d\u708e\u75c5\u6bd2\uff09\u5305\u819c\u86cb\u767d\uff08UniProt\uff1aQ76R62\uff09\u7684\u4e00\u90e8\u5206\uff0c\u5177\u6709T\u7ec6\u80de\u7684\u514d\u75ab\u539f\u6027\u3002<\/p>\n\n\n\n

<\/p>\n\n\n\n

HLA\u7c7b\u578b<\/h3>\n\n\n\n

HLA-A*02:01\uff0c \u4e2d\u56fd\u4eba\u5206\u5e03\u9891\u738712.036%<\/a><\/p>\n\n\n\n

<\/p>\n\n\n\n

\u6297\u539f\u548cHLA\u7684\u4eb2\u548c\u529b<\/h3>\n\n\n\n

<\/p>\n\n\n\n

NetMHCpan 4.1<\/strong> <\/a> \u8ba1\u7b97FLLTRILTI\u4e0eHLA-A*02:01\u4eb2\u548c\u529b\u4e3a 4.93 nM\uff0c\u4e3a\u7a33\u5b9a\u7ed3\u5408\u3002<\/p>\n\n\n\n

<\/p>\n\n\n\n

\u4ea7\u54c1\u7c7b\u578b\u548c\u5e94\u7528<\/h3>\n\n\n\n

<\/p>\n\n\n\n

\u4ea7\u54c1\u7c7b\u578b<\/td>\u89c4\u683c<\/td>\u4ef7\u683c<\/td><\/tr>
\u6d41\u5f0f\u68c0\u6d4b\u4e0e\u5206\u9009<\/td>Envelope protein (183-191) HLA-A*02:01 PE \/ APC \/ Alexa Fluor 488<\/td>7200\u5143\/50ug, 11800\u5143\/100ug<\/td><\/tr>
\u78c1\u73e0\u5206\u9009<\/td>Envelope protein (183-191) HLA-A*02:01 HLA-A*02:01\u78c1\u73e0<\/td>8200\u5143\/50ug, 12800\u5143\/100ug<\/td><\/tr>
\u751f\u7269\u7d20\u5316\u590d\u5408\u7269<\/td>Envelope protein (183-191) HLA-A*02:01 HLA-A*02:01-biotin<\/td>6800\u5143\/50ug, 11400\u5143\/100ug<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

\u5b9e\u6d4b\u7ed3\u679c<\/h3>\n\n\n\n

<\/p>\n\n\n\n

\u80bd\u523a\u6fc0PBMC\u540e\u68c0\u6d4b\u6297\u539f\u7279\u5f02\u6027CD8+T\u7ec6\u80de<\/h3>\n\n\n\n

FLLTRILTI\u591a\u80bd\u523a\u6fc0HLA-A*02:01\u9650\u5236\u6027PBMC\u540e\uff0c\u4f7f\u7528Envelope protein (183-191) HLA-A*02:01 PE \u56db\u805a\u4f53\u548c\u6297CD8-FITC\u6297\u4f53\u68c0\u6d4b\u3002\u4e0b\u56fe\u5de6\u56fe\u4e3a\u6297\u539f\u80bdFLLTRILTI\u523a\u6fc0\u7ec4\uff0c\u53f3\u56fe\u4e3a\u672a\u52a0\u6297\u539f\u80bd\u523a\u6fc0\u7ec4\u3002<\/p>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

\u9776\u70b9\u7ed3\u5408\u7684TCR\u5e8f\u5217<\/h3>\n\n\n\n

\u8bf7\u67e5\u770bIEDB\u6570\u636e\u5e93<\/a><\/p>\n\n\n\n

<\/p>\n\n\n\n

\u76f8\u5173\u6587\u7ae0<\/h3>\n\n\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Reference - PMID<\/th>Reference - Journal<\/th>Reference - Date<\/th>Reference - Title<\/th>\n<\/tr>\n<\/thead>\n
7527444<\/td>J Immunol<\/td>1994<\/td>The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.<\/td>\n<\/tr>\n
9239396<\/td>J Clin Invest<\/td>1997<\/td>Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.<\/td>\n<\/tr>\n
9780224<\/td>J Immunol<\/td>1998<\/td>Human class I supertypes and CTL repertoires extend to chimpanzees.<\/td>\n<\/tr>\n
8837608<\/td>Nat Med<\/td>1996<\/td>The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.<\/td>\n<\/tr>\n
8794355<\/td>J Virol<\/td>1996<\/td>Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.<\/td>\n<\/tr>\n
11035120<\/td>J Immunol<\/td>2000<\/td>Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.<\/td>\n<\/tr>\n
17942551<\/td>J Virol<\/td>2008<\/td>Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.<\/td>\n<\/tr>\n
18234055<\/td>Clin Exp Immunol<\/td>2008<\/td>A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients.<\/td>\n<\/tr>\n
18612271<\/td>Mol Ther<\/td>2008<\/td>The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.<\/td>\n<\/tr>\n
19542448<\/td>J Immunol<\/td>2009<\/td>Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.<\/td>\n<\/tr>\n
19734234<\/td>J Immunol<\/td>2009<\/td>Quantitating T cell cross-reactivity for unrelated peptide antigens.<\/td>\n<\/tr>\n
23251518<\/td>PLoS One<\/td>2012<\/td>Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes.<\/td>\n<\/tr>\n
16537621<\/td>J Virol<\/td>2006<\/td>Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection.<\/td>\n<\/tr>\n
23908113<\/td>J Clin Invest<\/td>2013<\/td>Mobilizing monocytes to cross-present circulating viral antigen in chronic infection.<\/td>\n<\/tr>\n
25051027<\/td>PLoS One<\/td>2014<\/td>A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.<\/td>\n<\/tr>\n
25016223<\/td>J Hepatol<\/td>2014<\/td>Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation.<\/td>\n<\/tr>\n
28792537<\/td>PLoS One<\/td>2017<\/td>Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.<\/td>\n<\/tr>\n
29180767<\/td>Sci Rep<\/td>2017<\/td>Frequency and reactivity of antigen-specific T cells were concurrently measured through the combination of artificial antigen-presenting cell, MACS and ELISPOT.<\/td>\n<\/tr>\n
30006605<\/td>Nat Commun<\/td>2018<\/td>Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.<\/td>\n<\/tr>\n
15726541<\/td>Hepatology<\/td>2005<\/td>Acute phase HBV-specific T cell responses associated with HBV persistence after HBV\/HCV coinfection.<\/td>\n<\/tr>\n
30518652<\/td>J Virol<\/td>2019<\/td>Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.<\/td>\n<\/tr>\n
30580250<\/td>Gut<\/td>2019<\/td>Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.<\/td>\n<\/tr>\n
30622109<\/td>Gut<\/td>2019<\/td>Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load.<\/td>\n<\/tr>\n
30711630<\/td>Gastroenterology<\/td>2019<\/td>Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.<\/td>\n<\/tr>\n
23011082<\/td>J Gastroenterol<\/td>2013<\/td>Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation.<\/td>\n<\/tr>\n
33205065<\/td>Cell Rep Med<\/td>2020<\/td>Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.<\/td>\n<\/tr>\n
35224746<\/td>Aliment Pharmacol Ther<\/td>2022<\/td>Model to predict on-treatment restoration of functional HBV-specific CD8<sup>+<\/sup> cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B.<\/td>\n<\/tr>\n
35464415<\/td>Front Immunol<\/td>2022<\/td>Screening and Identification of HBV Epitopes Restricted by Multiple Prevalent HLA-A Allotypes.<\/td>\n<\/tr>\n
34377970<\/td>JHEP Rep<\/td>2021<\/td>Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.<\/td>\n<\/tr>\n
36211805<\/td>Oncoimmunology<\/td>2022<\/td>Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients.<\/td>\n<\/tr>\n
38808361<\/td>Clin Mol Hepatol<\/td>2024<\/td>Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n

Views: 6<\/p>","protected":false},"excerpt":{"rendered":"

\u9776\u70b9\u8bf4\u660e Envelope protein (183-191) FLLTRILTI HLA-A*02:01 \u6765…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"class_list":["post-757","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages\/757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=757"}],"version-history":[{"count":8,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages\/757\/revisions"}],"predecessor-version":[{"id":1084,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages\/757\/revisions\/1084"}],"wp:attachment":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}